Mayo Clinic is the first facility approved to manufacture Choline C 11 Injection
Silver Spring, Maryland–(ENEWSPF)–September 12, 2012. The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.
Choline C 11 Injection is administered intravenously to produce an image that helps to locate specific body sites for follow-up tissue sampling and testing in men with recurrent…
